Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]